Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Doxorubicin Postoperatively for Anaplastic Thyroid Cancer
NCT00804830Phase 2Terminated
- Sponsor
- Region Skåne
- Start
- Apr 2008
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in anaplastic thyroid cancer (ATC), sponsored by Region Skåne. Started Apr 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NCT00804830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00804830.